Ouabain effect on myocardial mechanical function and sodium pump in the fetus

Area of Science:

• Cardiovascular Physiology
• Developmental Biology
• Pharmacology

Background:

• Ouabain is a cardiac glycoside affecting heart contractility and sodium pump activity.
• Age-related differences in cardiac function and drug response are critical in developmental studies.

Purpose of the Study:

• To investigate the effects of ouabain on fetal and newborn rabbit hearts.
• To compare the mechanical function, sodium pump activity, and toxicity of ouabain between fetal and newborn rabbits.

Main Methods:

• Isolated arterially perfused fetal and newborn rabbit hearts were used.
• Myocardial 86Rubidium (86Rb+) uptake measured sodium pump activity.
• Mechanical function assessed by changes in contractility and resting tension.

Main Results:

• Ouabain exhibited similar inotropic effects in both fetal and newborn hearts.
• Fetal hearts showed mechanical toxicity at lower ouabain concentrations (2.5 X 10(-6) M) than newborn hearts.
• Inhibition of sodium pump activity and potassium loss were comparable between fetuses and newborns.

Conclusions:

• Fetal rabbit hearts are more susceptible to ouabain-induced mechanical toxicity than newborn hearts.
• This increased toxicity in fetuses may be linked to heightened sensitivity to calcium, not differences in sodium pump activity.
• Findings suggest calcium handling differences contribute to ouabain toxicity variations during development.